v ::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::
ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

PREGNANCY OUTCOME IN CASES OF OLIGOHYDRAMNIOS AFTER 28 WEEKS OF GESTATION

AUTHORS:

Dr Nukhba Ghani Sheikh, Dr Beenish Jamshaid, Dr Mir Sanam Ijaz.

ABSTRACT:

Introduction: Volume of amniotic fluid can be a concern for foetal, placental and maternal pathology in fluid development or circulation. Some reports demonstrate that the amniotic fluid index [AFI] is a weak indicator for the undesirable effect of birth, but others have not verified that the adverse perinatal effect is linked with oligohydramnios. Objective: Comparing delivery mode and neonatal result in patients with oligohydramnios [AFI < 5 cm] with a group of no-oligohydramnios [AFI 5–25 cm]. Methods: In the Department of Gynaecology and Obstetrics, Services Hospital, a possible research-based observational analysis was carried out. For 1 year, the Oligohydramnios group was composed of 100 patients with 28 weeks AFI < 5 cm gestation, and of the No-oligohydramnios group, 100 patients with AFI 5–25 cm were enrolled. Results: During the study from 28 August 2018 to 21 September 2019 a total of 8,096 women were admitted. Among them, 100 patients were taken into the community of oligohydramnios who met the inclusion criterion. Increased operational performance [85 [85 per cent]] was observed in the oligohydramnios group, while in the no-oligohydramnios group it was 30 [30 per cent]. The neonatal result measured by Apgar score [P < 0.003] and admission to the Neonatal Intensive Care Unit [P < 0.026] was slightly different between the two parties. Conclusion: Isolated oligohydramnios is correlated with the need for operative action in the absence of some other maternal or foetal complicating factor and adversely affects the foetal outcome as compared to the no-oligohydramnios community with usual AFIs.

FULL TEXT

<
Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.